Associate Director Licensing & Acquisition and Business Integration Lead Own Brands
This role is a strategic and execution-focused business development position within DKSH Healthcare’s Own Brands division. You will manage the full lifecycle of M&A, in-licensing, and out-licensing deals, from sourcing and due diligence to contract negotiation and post-deal integration. The role requires deep pharmaceutical industry expertise and the ability to operate across a complex, global, matrixed organization. You will partner with cross-functional teams to drive growth, value realization, and EBIT outcomes for the portfolio.
50k new jobs listed every day. Install TAL to find more jobs like this.
Experience
12-15 years
Function
Business Development
Work mode
Onsite, Singapore
Company
Tier 2
What you will work on
This role is a strategic and execution-focused business development position within DKSH Healthcare’s Own Brands division. You will manage the full lifecycle of M&A, in-licensing, and out-licensing deals, from sourcing and due diligence to contract negotiation and post-deal integration. The role requires deep pharmaceutical industry expertise and the ability to operate across a complex, global, matrixed organization. You will partner with cross-functional teams to drive growth, value realization, and EBIT outcomes for the portfolio.
TAL's take
Role is a high-level strategic position at a large, stable global organization with clear end-to-end responsibilities.
The JD is very clear about the strategic, deal-making, and integration requirements for the specific healthcare own-brands business unit.
Must haves
- 12–15 years experience in pharmaceutical or healthcare industry
- Proven track record in business development, licensing, and M&A
- Experience leading end-to-end deal processes
- Strong commercial acumen in pharma portfolio strategy
- Experience working cross-functionally in regional or global environments
- Strong stakeholder management and influencing skills
About the company
Established multinational with $11B+ sales, significant global operations but not a pure-play tech company.